← Back to Clinical Trials
Recruiting NCT07658066

NCT07658066 Use of Football in Programs to Reduce Stigma Toward Mental Illness: A Comparison of the Effectiveness of Contact Interaction and Video-Based Approaches

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07658066
Status Recruiting
Phase
Sponsor Kaohsiung Medical University Chung-Ho Memorial Hospital
Condition Psychiatry
Study Type INTERVENTIONAL
Enrollment 210 participants
Start Date 2026-03-02
Primary Completion 2027-07-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 30 Years
Study Type INTERVENTIONAL
Interventions
Contact-Based EducationVideo + Contact-Based EducationFootball + Contact-Based Education

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 210 participants in total. It began in 2026-03-02 with a primary completion date of 2027-07-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to evaluate the effectiveness of football-based interventions in reducing stigma toward mental illness among university students. The main questions it aims to answer are: * Does participating in a contact-based education program involving football help reduce stigma toward mental illness among university students? * What are the effects of three different intervention methods on reducing stigma toward mental illness? Researchers will compare the traditional contact-based education program with the other two interventions to evaluate their differences in effectiveness. Participants will: * Be randomly assigned to one of the three intervention groups. * Complete online assessments to measure attitudes toward mental illness before and after the intervention. * Participate in qualitative interviews to provide in-depth feedback on their experiences and perceptions.

Eligibility Criteria

Inclusion Criteria: * University students currently enrolled, aged between 18 and 30 years. * In good physical condition with no contraindications to exercise (i.e., not diagnosed by a physician or advised to avoid physical activity, and with no items selected on the PAR-Q+ \[Physical Activity Readiness Questionnaire for Everyone\]). * Able to follow the study procedures and provide signed informed consent. Exclusion Criteria: * Individuals who are unable to safely participate in football activities due to intellectual disability, pregnancy, head injury, cardiovascular disease, or other neuromuscular or musculoskeletal disorders. * Individuals who are unable to effectively participate in the intervention program or complete assessments due to significant emotional disturbances, personality disorders, substance (alcohol) abuse, or severe mental illness.

Contact & Investigator

Central Contact

Ming-De Chen, Ph.D.

✉ mdchen@kmu.edu.tw

📞 +886-73121101

Principal Investigator

Ming-De Chen, Ph.D.

STUDY CHAIR

Kaohsiung Medical University Chung-Ho Memorial Hospital

Frequently Asked Questions

Who can join the NCT07658066 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 30 Years, studying Psychiatry. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07658066 currently recruiting?

Yes, NCT07658066 is actively recruiting participants. Contact the research team at mdchen@kmu.edu.tw for enrollment information.

Where is the NCT07658066 trial being conducted?

This trial is being conducted at Kaohsiung City, Taiwan.

Who is sponsoring the NCT07658066 clinical trial?

NCT07658066 is sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. The principal investigator is Ming-De Chen, Ph.D. at Kaohsiung Medical University Chung-Ho Memorial Hospital. The trial plans to enroll 210 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology